In RDS which is damaged?
The core concept here is the pathophysiology of RDS. In NRDS, the main issue is a deficiency of surfactant. Surfactant is produced by type II alveolar cells and helps reduce surface tension in the alveoli, preventing them from collapsing. Without enough surfactant, the alveoli collapse, leading to atelectasis and respiratory distress.
So the correct answer would be related to surfactant deficiency. Now, looking at the options, even though they're not provided, typical wrong options might include things like increased surfactant, alveolar wall thickening, or other structural issues. The incorrect options need to be explained as to why they're wrong. For example, if an option says "alveolar walls," that's not the primary issue here. The problem is the lack of surfactant leading to alveolar collapse, not the walls themselves being damaged.
Clinical pearls should highlight that surfactant deficiency is the key in NRDS, and that treatment involves exogenous surfactant administration. Also, premature infants are at higher risk because their lungs haven't developed enough to produce surfactant.
Now, structuring the explanation with the required sections. Make sure each part is concise and fits within the character limit. Use bold for section headers and key terms. Check that explanations for each wrong option are clear and specific. Avoid any markdown except where specified. Keep the language precise but accessible for postgraduate students. Finally, confirm the correct answer is highlighted properly.
**Core Concept**
Respiratory Distress Syndrome (RDS) in neonates is primarily caused by **surfactant deficiency**, leading to **alveolar collapse** and **increased work of breathing**. Surfactant, produced by type II pneumocytes, reduces alveolar surface tension. Its absence causes **atelectasis**, **hypoxemia**, and **respiratory acidosis**.
**Why the Correct Answer is Right**
In Neonatal Respiratory Distress Syndrome (NRDS), the **lack of pulmonary surfactant** is the central pathophysiological defect. Surfactant deficiency increases alveolar surface tension, causing alveolar collapse during exhalation. This results in **decreased functional residual capacity**, **hypoxia**, and **respiratory distress**. Premature infants (<34 weeks) are most affected due to immature type II alveolar cells.
**Why Each Wrong Option is Incorrect**
**Option A:** *Alveolar wall thickening* is seen in interstitial lung diseases (e.g., pulmonary fibrosis), not RDS.
**Option B:** *Bronchial smooth muscle hyperplasia* is characteristic of asthma, not RDS.
**Option C:** *Capillary endothelial damage* occurs in ARDS, not NRDS.
**Clinical Pearl / High-Yield Fact**
**Surfactant replacement therapy** is the cornerstone of RDS management